Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trident Texofab's Days Sales Outstanding for the
three
months ended in Mar. 2026 was 131.98.
Trident Texofab's Days Inventory for the
three
months ended in Mar. 2026 was 56.69.
Trident Texofab's Days Payable for the
three
months ended in Mar. 2026 was 35.98.
Therefore, Trident Texofab's Cash Conversion Cycle (CCC) for the
three
months ended in Mar. 2026 was 152.69.
Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.
Be Aware
CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.
The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.
Trident Texofab Cash Conversion Cycle Related Terms
Trident Texofab Cash Conversion Cycle Historical Data
* Premium members only.
The historical data trend for Trident Texofab's Cash Conversion Cycle can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Textile Manufacturing subindustry, Trident Texofab's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Trident Texofab Cash Conversion Cycle vs Manufacturing - Apparel & Accessories Industry
For the Manufacturing - Apparel & Accessories industry and Consumer Cyclical sector, Trident Texofab's Cash Conversion Cycle distribution charts can be found below:
* The bar in red indicates where Trident Texofab's Cash Conversion Cycle falls into.
Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.
Cash Conversion Cycle is one of several measures of management effectiveness.
Trident Texofab's Cash Conversion Cycle for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trident Texofab (BOM:540726) has a Cash Conversion Cycle of 152.69 as of Mar. 2026. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Trident Texofab and its competitors.
Is Trident Texofab's Cash Conversion Cycle too high?
Trident Texofab's current Cash Conversion Cycle is 152.69. The Manufacturing - Apparel & Accessories industry median Cash Conversion Cycle is 124.59. Trident Texofab's value of 152.69 is 22.6% above this industry median. Overall, Trident Texofab has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Texofab's Cash Conversion Cycle compare to competitors?
Trident Texofab's Cash Conversion Cycle of 152.69 can be compared against companies in the Manufacturing - Apparel & Accessories industry. The industry median Cash Conversion Cycle is 124.59. Trident Texofab's value of 152.69 is 22.6% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Conversion Cycle for a Manufacturing - Apparel & Accessories company?
The median Cash Conversion Cycle among Manufacturing - Apparel & Accessories companies is 124.59, based on 1,039 companies in the industry. Companies in the top quartile (top 25%) have a Cash Conversion Cycle significantly above this median, while those in the bottom quartile fall well below. However, Cash Conversion Cycle should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Trident Texofab's current Cash Conversion Cycle of 152.69 is 22.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Conversion Cycle mean?
A high Cash Conversion Cycle can signal that a stock is expensive relative to its fundamentals. Cash conversion cycle equals sum of days inventory and days sales outstanding less days payable. View historical data on Trident Texofab and its competitors. For the Manufacturing - Apparel & Accessories industry, the median Cash Conversion Cycle is 124.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Texofab's current Cash Conversion Cycle is 152.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Texofab stock overvalued right now?
Based on GuruFocus' analysis, Trident Texofab (BOM:540726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹63.35, compared to a current price of ₹32.25 — trading 49.1% below its estimated fair value. The current Cash Conversion Cycle is 152.69 and 22.6% above the Manufacturing - Apparel & Accessories industry median of 124.59. Trident Texofab's overall GF Score™ is 64/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Conversion Cycle calculated?
Cash Conversion Cycle is calculated from a company's financial statements. For Trident Texofab (BOM:540726), the current Cash Conversion Cycle is 152.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Texofab (BOM:540726) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Texofab stock appears to be undervalued.
The current stock price of ₹32.25 is trading 49.1% below its estimated GF Value™ of ₹63.35.
GuruFocus considers Trident Texofab to be Possible Value Trap.
Key valuation signals for BOM:540726:
Cash Conversion Cycle: 152.69
GF Value™: ₹63.35 vs. price of ₹32.25 (49.1% below fair value)
Industry Position: 22.6% above the Manufacturing - Apparel & Accessories median
No single metric tells the full story. See the BOM:540726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. Its brands are Storia Of Shed, Light Trail, Comfy Zoi, and Alicon. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.
64GF Score
Get the complete analysis for BOM:540726
Cash Conversion Cycle is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:540726 has been successfully added to your 
